bian zhe tui jian

..............page:2571

quan qiu hua xin ju mian : dui yi yao wei sheng he jian guan ji gou yun yi shen yuan
margaret a.hamburg; dong ke ; yao li xin ; qiu qiong ;

..............page:2575-2579

WINDOW OF NEW DRUGS

..............page:2581-2582

International Pharmacovigilance Flash
ben kan bian yi ;

..............page:2583-2584

The new prostacyclin analog treprostinil
GU Zhi-chun;LIU Xiao-yan;SHEN Jie-yan;CAI Zong-ye;Department of Pharmacy;School of Medicine;Shanghai Jiao Tong University;Department of Cardiology;Ren Ji Hospital;School of Medicine;Shanghai Jiao Tong University;

..............page:2585-2588+2592

Comparison of drug post-marketing studies among the different agencies
ZHAO Jian-zhong;XIE Song-mei;YANG Jin-bo;WANG Tao;Center for Drug Evaluation;China Food and Drug Administration;

..............page:2589-2592

Appropriateness analysis for the regulation of drug post-marketing safety between the government and pharmaceutical companies
ZHANG Hao;WU Zhi-ang;College of Business Administration;Shenyang Pharmaceutical University;

..............page:2593-2596+2623

Rules and regulations for off-label use of drug in US from the perspective of risk regulation
XU Rong;SUN Xin-xin;SHAO Ming-li;China Pharmaceutical University;School of Pharmacy;Shanghai Jiaotong University;

..............page:2597-2601+2650

Research and development of the pediatric drugs in China:status and problem analysis
GUO Zhi-gang;WU Bin;GUAN Xiao-dong;CONG Luo-luo;SHI Lu-wen;School of Pharmaceutical Sciences;Peking University;Beijing Food and Drug Administration;International Research Center of Medicinal Administration;Peking University;

..............page:2602-2606

Establishment and advance of guidance system of nonclinical evaluation for pharmaceuticals in China
WANG Qing-li;Center for Drug Evaluation;China Food and Drug Administration;

..............page:2607-2610+2658

Effect of compound reserpine on intestinal flora in mice
LI Hui-fen;CAO Yun-fei;CUI Wei-liang;ZHANG Xue-lan;TIAN Jing-zhen;Shandong University of Traditional Chinese Medicine;Shandong Institute for Food and Drug Control;

..............page:2611-2613+2663

Simultaneous determination of fifteen components in Shuanghuanglian powder for injection by HPLC
LI Wen-chun;SUN Yong-hui;XIE Li-wen;FU Rao;LI Chang-xin;SU De-long;WANG Ying-xin;Research & Development Center of Medicine;Harbin No.2 Chinese Medicine Factory;Harbin Pharmaceutical Group Co.;Ltd.;Research Institute of Chinese Medicine;Heilongjiang University of Chinese Medicine;

..............page:2614-2618+2630

Isolation of endophytic bacteria from Acanthopanax senticosus and their antimicrobial activities
GUO Xiao-lu;LU Bin-yu;ZHENG Chun-ying;Laboratory of Microbiology;Life Science College;Heilongjiang University;

..............page:2619-2623

Advance in research of anti-HCV drugs and therapies
YANG Xiao-yu;WANG Ju-xian;Beijing Hondsen Pharmaceutical Technology Co.;Ltd.;Institute of Medicinal Biotechnology;Beijing Union Medical College;Chinese Academy of Medical Sciences;

..............page:2624-2630

Application of polymeric micelles as new nanocarriers in cancer diagnosis and therapy
XIAO Ya-nan;ZHANG Na;School of Pharmaceutical Sciences;Shandong University;

..............page:2631-2636+2670

Progress in synthesis research of the new proton pump inhibitor tenatoprazole
YAN Feng;MIN Jie;GUAN Jin;LIU Zhi-han;School of Applied Chemistry;Shenyang University of Chemical Technology;

..............page:2637-2642

Quality control of clinical trial institution and the analysis of influence factors
ZHANG Yang;ZHAO Hong-yun;CAO Ye;GUO Ying;SUN Jian;LI Su;ZHANG Li;HONG Ming-huang;State Key Laboratory of Oncology in South China;Sun Yet-sen University;Clinical Trials Center;Cancer Center;Sun Yet-sen University;Department of Medical Oncology;Cancer Center;Sun Yet-sen University;

..............page:2643-2646

A new electronic administration system of clinical trials in our hospital
WANG Ju-yong;XIAO Zhen;NI Shuang;LIU Tao;CHEN Chao;WANG Fang-yuan;Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;

..............page:2647-2650

Effect of low dose ketamine on visceral pain following laparoscopic cholecystectomy
WU Chang-yi;YUE Feng;ZHANG Li-ping;Department of Anesthesiology;Peking University Third Hospital;

..............page:2651-2654

A randomized controlled clinical trials for the treatment of type 2 diabetes by vildagliptin and alpha-glucosidase inhibitor
SU Yong;L Li-fang;LI Quan-zhong;ZHAO Zhi-gang;Department of Endocrinology;Zhengzhou University People’s Hospital;

..............page:2655-2658

Pharmacokinetics of deoxypodophyllotoxin polymeric micelles in rats
ZHAO Jin;SHI Ji-feng;XIONG Ye-rong;TU Jia-sheng;Department of Pharmaceutics;China Pharmaceutical University;

..............page:2659-2663

Optimization of smoked processing technology of Angelicae Sinensis Radix based on an AHP combined with BPNN model
GU Zhi-rong;PAN Xin-bo;WANG Ya-li;SUN Yu-jing;Institute of Angelica Sinensis;Gansu University of Traditional Chinese Medicine;Center of Scientific Experiment;Gansu University of Traditional Chinese Medicine;

..............page:2664-2670

Preparation of controlled osmotic pump tablets of losartan potassium and hydrochlorothiazide and the optimization of formulation by central composite design
LUO Dan-chao;WEIYANG Yi-fang;JIANG Jie;LI Ning;GAO Chong-kai;Department of Pharmaceutics;School of Guangdong Pharmaceutical University;

..............page:2671-2677+2686

TLC identification and content determination of Lignum caraganae
ZHANG Xing-fu;LUO Gui-fa;WANG Yan;Qinghai Institute for Food and Drug Control;

..............page:2678-2680+2693

Determination of free and total platinum levels in biological samples by graphite furnace atomic absorption spectroscopy
WANG Shi-liang;HE Zhi-xia;CHEN Dian-liang;CHU Cheng-ding;YE Hong-yang;JIANG Ling;Anhui Professional and Technical College;Sustained-Release Drug Laboratory of Hefei University of Technology;College of Public Health;Anhui Medical University;

..............page:2681-2686

Purification and mass spectrometric analysis of spirulinakinase
HE Qiu-jing;ZHANG Chun-long;PANG Hui;CHEN Meng;WANG Hui-jie;Guangxi Medical University;Guangdong Medical College;

..............page:2687-2693

Expert consensus on adverse event management of everolimus
Expert Group of Adverse Event Management of Everolimus;ZHOU Ai-ping;Cancer Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;

..............page:2694-2700

Literature analysis of adverse drug reactions induced by duloxetine
ZHAO Ming;LIANG Liang;ZHU Yuan-chao;YANG Li-ping;Department of Pharmacy;Beijing Hospital;Ministry of Health;Beijing Key Laboratory of Assessment of Clinical Drug Risk and Individualized Application;National Clinical Research Center of Respiratory Diseases;

..............page:2701-2704